Cartesian Therapeutics

IPO

Cartesian Therapeutics is a biotech company in Gaithersburg, United States, founded in 2016. It has raised $7.3M across 4 rounds, most recently a $3.0M Grant in June 2024.

Home - Cartesian Therapeutics

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$7.3M
Last Round
$3.0M GrantJun 2024
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Cartesian Therapeutics is a NASDAQ-listed clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases. Its lead program, Descartes-08, is an autologous mRNA-engineered CAR-T therapy targeting BCMA in patients with myasthenia gravis and other autoimmune conditions. Founded in 2016, the company merged with Selecta Biosciences in November 2023 and is based in Gaithersburg, Maryland.

Summary

It lists 51–200 employees. It has raised $7.3M in total across 4 rounds, most recently a $3.0M Grant round in Jun 2024. Investors include HBM Healthcare Investments, Invus and Schooner Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Secondary MarketSecondary MarketJul 2024

Sign up to see all 6 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cartesian Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/cartesian-therapeutics"><img src="https://indexed.vc/api/badge/company/cartesian-therapeutics" alt="Cartesian Therapeutics on Indexed.vc" width="260" height="76" /></a>